Skip to content

Genetic Inclusion by Virtual Evaluation

Virtual Platforms for Genetics Evaluation in the Medically Underserved

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05318222
Acronym
GIVE
Enrollment
200
Registered
2022-04-08
Start date
2022-06-01
Completion date
2027-01-31
Last updated
2025-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Birth Defects, Multiple Congenital Anomaly, Neurodevelopmental Disorders

Brief summary

This study aims to transform the current clinical practice paradigm by leveraging an internally designed web-based model of delivery of care called Consultagene to provide remote evaluation and genomic sequencing for improving genetic health of less resourced children with rare disorders living along the Texas-Mexico border.

Detailed description

Inadequate access to genetics evaluation and genomic testing in the Hispanic minorities living along the Texas-Mexico has marginalized the most vulnerable pediatric group. In this study, we will (1) implement a virtual web-based service, called Consultagene for simplifying patient pathways and deliver virtual genetics evaluation in Rio Grande Valley (RGV) (2) provide rapid genetic diagnoses through whole genome sequencing and interpretation of diagnostic studies for medical decision-making and improving health outcomes for the minorities, and (3) build genomic competency of front-line healthcare providers through education and machine learning to expedite referral of pediatric patients with suspected rare diseases for shortening diagnostic odyssey.

Interventions

WGS will identify copy number variations (CNVs), single nucleotide variants (SNVs), as well as triplet repeat disorders in children with rare diseases

Sponsors

Baylor College of Medicine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Days to 18 Years
Healthy volunteers
Yes

Inclusion criteria

Pediatric patients with undiagnosed rare genetic diseases residing in the Rio Grande Valley and El Paso in Texas

Exclusion criteria

Children with known genetic diseases

Design outcomes

Primary

MeasureTime frame
Time to diagnosis12 months

Countries

United States

Contacts

Primary ContactSeema Lalani, MD
seemal@bcm.edu832-822-4280
Backup ContactBrendan Lee, MD; PhD
blee@bcm.edu832-822-4280

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026